Publication | Closed Access

The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial

UrologyRenal FunctionKidney FailureChronic Kidney DiseaseGenetic EpidemiologyRenal PathologyRenal InflammationJapanese Patient SubsetTempo 3:4Subgroup AnalysisMedicineNephrologyKidney Research